Literature DB >> 22200978

RNA interference against MDM2 suppresses tumor growth and metastasis in pancreatic carcinoma SW1990HM cells.

Weidong Shi1, Zhiqiang Meng, Zhen Chen, Yongqiang Hua, Huifeng Gao, Peng Wang, Junhua Lin, Zhenhua Zhou, Jianmin Luo, Luming Liu.   

Abstract

In our previous study, the mouse double minute 2 (MDM2) was identified as one of the leading genes that promote the metastasis of pancreatic cancer (PC). However, the mechanism by which MDM2 promotes metastasis of PC is not understood. In this study, we show that down-regulation of MDM2 through lentivirus-mediated RNA interference could also suppress in vitro proliferation and in vivo tumor growth, and led to an obvious inhibition of both in vitro invasion and in vivo live metastases of SW1990HM cells which had an over-expression of MDM2 and a higher metastatic potential. Moreover, we also show that the down-regulation of MDM2 induced a significant decrease in MMP9, Ki-67 and increase in P53, E-Cadherin expression, and results in an altered expression of genes involved in metastasis, apoptosis, and cell proliferation. Our results suggest that MDM2 plays an important role in metastasis as well as tumor growth of PC. MDM2 could be a hopeful target for the control of PC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200978     DOI: 10.1007/s11010-011-1208-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

1.  MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.

Authors:  Jiabei Wang; Tongsen Zheng; Xi Chen; Xuan Song; Xianzhi Meng; Nishant Bhatta; Shangha Pan; Hongchi Jiang; Lianxin Liu
Journal:  J Gastroenterol Hepatol       Date:  2011-02       Impact factor: 4.029

2.  Proteome analysis of human pancreatic cancer cell lines with highly liver metastatic potential by antibody microarray.

Authors:  Weidong Shi; Zhiqiang Meng; Zhen Chen; Jianmin Luo; Luming Liu
Journal:  Mol Cell Biochem       Date:  2010-10-20       Impact factor: 3.396

3.  MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population.

Authors:  Gangqiao Zhou; Yun Zhai; Ying Cui; Xiumei Zhang; Xiaojia Dong; Hao Yang; Ying He; Kaitai Yao; Hongxing Zhang; Lianteng Zhi; Xiaoyan Yuan; Wei Qiu; Xiaoai Zhang; Yan Shen; Boqing Qiang; Fuchu He
Journal:  Clin Cancer Res       Date:  2007-05-01       Impact factor: 12.531

4.  TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer.

Authors:  Shinako Araki; Jacob A Eitel; Christopher N Batuello; Khadijeh Bijangi-Vishehsaraei; Xian-Jin Xie; David Danielpour; Karen E Pollok; David A Boothman; Lindsey D Mayo
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

Review 5.  Recent advances in validating MDM2 as a cancer target.

Authors:  Elizabeth R Rayburn; Scharri J Ezell; Ruiwen Zhang
Journal:  Anticancer Agents Med Chem       Date:  2009-10       Impact factor: 2.505

6.  Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysis.

Authors:  Wei-Dong Shi; Zhi-Qiang Meng; Zhen Chen; Jun-Hua Lin; Zhen-Hua Zhou; Lu-Ming Liu
Journal:  Cancer Lett       Date:  2009-04-17       Impact factor: 8.679

7.  MDM2 gene amplification in metastatic osteosarcoma.

Authors:  M Ladanyi; C Cha; R Lewis; S C Jhanwar; A G Huvos; J H Healey
Journal:  Cancer Res       Date:  1993-01-01       Impact factor: 12.701

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.

Authors:  C Zietz; M Rössle; C Haas; A Sendelhofert; A Hirschmann; M Stürzl; U Löhrs
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

10.  Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.

Authors:  K Martin; D Trouche; C Hagemeier; T S Sørensen; N B La Thangue; T Kouzarides
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

View more
  8 in total

1.  An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis.

Authors:  Hiroyuki Katayama; Clayton Boldt; Jon J Ladd; Melissa M Johnson; Timothy Chao; Michela Capello; Jinfeng Suo; Jianning Mao; JoAnn E Manson; Ross Prentice; Francisco Esteva; Hong Wang; Mary L Disis; Samir Hanash
Journal:  Cancer Res       Date:  2015-06-18       Impact factor: 12.701

Review 2.  Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.

Authors:  Haojun Shi; Ji Li; Deliang Fu
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-07       Impact factor: 4.553

3.  Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis.

Authors:  Atul Ranjan; Kaustav Bera; Tomoo Iwakuma
Journal:  Hepatoma Res       Date:  2016-05-06

4.  MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9.

Authors:  Xiaofeng Chen; Jinrong Qiu; Dapeng Yang; Jianlei Lu; Caiyun Yan; Xiaoming Zha; Yongmei Yin
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

5.  Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy.

Authors:  Shih-Hung Yang; Jen-Chieh Lee; Jhe-Cyuan Guo; Sung-Hsin Kuo; Yu-Wen Tien; Ting-Chun Kuo; Ann-Lii Cheng; Kun-Huei Yeh
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

Review 6.  Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations.

Authors:  Toshinori Ozaki; Meng Yu; Danjing Yin; Dan Sun; Yuyan Zhu; Youquan Bu; Meixiang Sang
Journal:  BMC Cancer       Date:  2018-03-20       Impact factor: 4.430

7.  MDM2 Overexpression Modulates the Angiogenesis-Related Gene Expression Profile of Prostate Cancer Cells.

Authors:  Thiagarajan Venkatesan; Ali Alaseem; Aiyavu Chinnaiyan; Sivanesan Dhandayuthapani; Thanigaivelan Kanagasabai; Khalid Alhazzani; Priya Dondapati; Saad Alobid; Umamaheswari Natarajan; Ruben Schwartz; Appu Rathinavelu
Journal:  Cells       Date:  2018-05-10       Impact factor: 6.600

8.  LncRNA HCG11/miR-579-3p/MDM2 axis modulates malignant biological properties in pancreatic carcinoma via Notch/Hes1 signaling pathway.

Authors:  Jin Xu; Weixue Xu; Xuan Yang; Zhen Liu; Qinyun Sun
Journal:  Aging (Albany NY)       Date:  2021-06-21       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.